Invention Grant
- Patent Title: Iridium/rhodium anti-cancer compounds
- Patent Title (中): 铱/铑抗癌化合物
-
Application No.: US13698965Application Date: 2011-05-20
-
Publication No.: US09408853B2Publication Date: 2016-08-09
- Inventor: Abraha Habtemariam , Zhe Liu , Joan Josep Soldevila , Ana Maria Pizarro , Peter John Sadler
- Applicant: Abraha Habtemariam , Zhe Liu , Joan Josep Soldevila , Ana Maria Pizarro , Peter John Sadler
- Applicant Address: GB Coventry
- Assignee: University of Warwick
- Current Assignee: University of Warwick
- Current Assignee Address: GB Coventry
- Agency: Nixon Peabody LLP
- Agent Hema Vakharia-Rao
- Priority: GB1008584.3 20100522
- International Application: PCT/GB2011/000776 WO 20110520
- International Announcement: WO2011/148124 WO 20111201
- Main IPC: A61K31/655
- IPC: A61K31/655 ; A61K31/555 ; A61K31/28 ; C07F15/00 ; C07F17/02
Abstract:
The present invention relates to novel iridium and/or rhodium containing complexes for use as a cytotoxic, such as an anti-cancer agent. There is also provided a method of preparing said compounds.
Public/Granted literature
- US20130065864A1 NOVEL IRIDIUM/RHODIUM ANTI-CANCER COMPOUNDS Public/Granted day:2013-03-14
Information query
